 |
PDBsum entry 3q2h
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3q2h
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
_ZN
×2
|
 |
|
|
|
|
|
|
|
_CD
×4
|
 |
|
|
|
|
|
|
|
_NI
×14
|
 |
|
|
|
|
|
|
|
_MG
×3
|
 |
|
|
|
|
|
|
|
_NA
×4
|
 |
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Bioorg Med Chem Lett
21:1376-1381
(2011)
|
|
PubMed id:
|
|
|
|
|
| |
|
The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis.
|
|
C.De Savi,
A.Pape,
J.G.Cumming,
A.Ting,
P.D.Smith,
J.N.Burrows,
M.Mills,
C.Davies,
S.Lamont,
D.Milne,
C.Cook,
P.Moore,
Y.Sawyer,
S.Gerhardt.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.De Savi,
A.Pape,
Y.Sawyer,
D.Milne,
C.Davies,
J.G.Cumming,
A.Ting,
S.Lamont,
P.D.Smith,
J.Tart,
K.Page,
and
P.Moore
(2011).
Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis.
|
| |
Bioorg Med Chem Lett,
21,
3301-3306.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |